PE20170447A1 - Metodo para la preparacion de imidazopiridazinas sustituidas - Google Patents

Metodo para la preparacion de imidazopiridazinas sustituidas

Info

Publication number
PE20170447A1
PE20170447A1 PE2017000372A PE2017000372A PE20170447A1 PE 20170447 A1 PE20170447 A1 PE 20170447A1 PE 2017000372 A PE2017000372 A PE 2017000372A PE 2017000372 A PE2017000372 A PE 2017000372A PE 20170447 A1 PE20170447 A1 PE 20170447A1
Authority
PE
Peru
Prior art keywords
compound
formula
preparation
reacting
obtaining
Prior art date
Application number
PE2017000372A
Other languages
English (en)
Inventor
Holger Paulsen
Uwe Muenster
Nicolas Guimond
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of PE20170447A1 publication Critical patent/PE20170447A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B41/00Formation or introduction of functional groups containing oxygen
    • C07B41/02Formation or introduction of functional groups containing oxygen of hydroxy or O-metal groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

SE REFIERE A UN METODO DE PREPARACION DEL COMPUESTO DE FORMULA (I) QUE COMPRENDE: A) HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA R1-OH OBTENIENDOSE EL COMPUESTO DE FORMULA (IV); B) HACER REACCIONAR EL COMPUESTO DE FORMULA (IV) CON UN COMPUESTO DE FORMULA R2-Y OBTENIENDOSE EL COMPUESTO DE FORMULA (VI); C) HACER REACCIONAR EL COMPUESTO DE FORMULA (VI) CON UN COMPUESTO DE FORMULA (VII) OBTENIENDOSE EL COMPUESTO DE FORMULA (I); DONDE LG1 ES BROMO; LG2 ES CLORO; LG3 ES IODO; R1 ES FENILO O HETEROARILO OPCIONALMENTE SUSTITUIDOS; R2 ES FENILO OPCIONALMENTE SUSTITUIDO; R3a ES ALQUILO C1-C6 OPCIONALMENTE SUSTITUIDO; R3b ES H O ALQUILO C1-C6 OPCIONALMENTE SUSTITUIDO
PE2017000372A 2014-09-01 2015-08-28 Metodo para la preparacion de imidazopiridazinas sustituidas PE20170447A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14183029 2014-09-01

Publications (1)

Publication Number Publication Date
PE20170447A1 true PE20170447A1 (es) 2017-05-18

Family

ID=51422014

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2017000372A PE20170447A1 (es) 2014-09-01 2015-08-28 Metodo para la preparacion de imidazopiridazinas sustituidas

Country Status (19)

Country Link
US (1) US20170305912A1 (es)
EP (1) EP3189055A1 (es)
JP (1) JP2017525725A (es)
KR (1) KR20170044166A (es)
CN (1) CN106795164A (es)
AR (1) AR101730A1 (es)
AU (1) AU2015311011A1 (es)
BR (1) BR112017003916A2 (es)
CA (1) CA2959224A1 (es)
CO (1) CO2017002070A2 (es)
IL (1) IL250264A0 (es)
MX (1) MX2017002749A (es)
PE (1) PE20170447A1 (es)
RU (1) RU2017110880A (es)
SG (1) SG11201700818XA (es)
TW (1) TW201613927A (es)
UY (1) UY36284A (es)
WO (1) WO2016034507A1 (es)
ZA (1) ZA201702297B (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070078136A1 (en) 2005-09-22 2007-04-05 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
TW201107329A (en) * 2009-07-30 2011-03-01 Oncotherapy Science Inc Fused imidazole derivative having ttk inhibitory action
TWI541243B (zh) * 2010-09-10 2016-07-11 拜耳知識產權公司 經取代咪唑并嗒
WO2014020041A1 (en) * 2012-08-02 2014-02-06 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer
WO2014080633A1 (en) 2012-11-21 2014-05-30 Raqualia Pharma Inc. Polymorph forms
TW201437211A (zh) 2013-03-01 2014-10-01 Bayer Pharma AG 經取代咪唑并嗒□
MX2015017245A (es) * 2013-06-13 2016-07-20 Bayer Pharma AG Combinacion de un derivado de imidazopiridazina y un agente mitotico para el tratamiento del cancer.

Also Published As

Publication number Publication date
SG11201700818XA (en) 2017-03-30
ZA201702297B (en) 2018-12-19
EP3189055A1 (en) 2017-07-12
RU2017110880A (ru) 2018-10-03
US20170305912A1 (en) 2017-10-26
KR20170044166A (ko) 2017-04-24
AU2015311011A1 (en) 2017-02-23
AR101730A1 (es) 2017-01-11
TW201613927A (en) 2016-04-16
MX2017002749A (es) 2017-07-26
CO2017002070A2 (es) 2017-05-19
CN106795164A (zh) 2017-05-31
WO2016034507A1 (en) 2016-03-10
CA2959224A1 (en) 2016-03-10
JP2017525725A (ja) 2017-09-07
BR112017003916A2 (pt) 2018-03-06
IL250264A0 (en) 2017-03-30
UY36284A (es) 2016-04-01

Similar Documents

Publication Publication Date Title
CY1120705T1 (el) Καινοφανεις αναστολεις αποακετυλασων ιστονων
PE20210922A1 (es) Pirimidinonas como inhibidores del factor xia
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
ECSP15043280A (es) Nuevos compuestos y composiciones para la inhibición de fasn
TR201906366T4 (tr) Polisiklik-karbamoilpiridon bileşiklerinin sentezi.
UY35333A (es) Compuestos de azabencimidazol
DK3233843T3 (da) Isoxazol-hydraxamsyreforbindelser som LPXC-hæmmere
DOP2016000242A (es) Uso de compuestos heterocíclicos para controlar nematodos
AR105821A1 (es) COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T
MA39843A (fr) Pyridine-2-amides utiles comme agonistes de cb2
BR112017003255A2 (pt) ?precursor para fazer um detergente, detergente e método para sua produção?
CL2018000962A1 (es) Oportunidades para el proceso de aumento de recuperación según se aplica a la producción de molibdeno
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
DK3186227T3 (da) Nye sulfonylaminobenzamid-forbindelser som anthelmintika
BR112014030126B8 (pt) Processos para produzir certos 2-(piridino-3-il)tiazóis
IN2014MU01192A (es)
AR098879A1 (es) Síntesis de ent-progesterona y sus productos intermedios
IN2014MU00195A (es)
EA201691362A1 (ru) Способы получения конденсированных гетероциклических модуляторов ионных каналов
PE20170447A1 (es) Metodo para la preparacion de imidazopiridazinas sustituidas
DK3353147T3 (da) Syntese af terphenylforbindelser
BR112016023767A2 (pt) forma sólida, composição farmacêutica, compostos, métodos, composições e utilizações
DK201300179U1 (da) Kemisk forbindelse med nyttige egenskaber
EA201790238A1 (ru) Кристаллические ингибиторы bace
SV2016005190A (es) Nuevo inhibidor de sglt1

Legal Events

Date Code Title Description
FD Application declared void or lapsed